Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 234 posts found.

Takeda and Teva set out generics joint venture plan

January 4, 2016
Sales and Marketing Takeda, Teva, generics, joint venture

Takeda and Teva have detailed plans for a new joint venture to create a new company to market off-patent generic …

News
Teva image

Teva strips $1 billion worth of assets to clear Allergan deal

December 4, 2015
Medical Communications, Sales and Marketing Allergan, Teva, acquisitions, divestments, mergers

Teva Pharmaceuticals is thought to be in the process of stripping nearly $1 billion worth of assets to address antitrust …

News
Teva image

Teva and Heptares enter $400m agreement for small-molecule migraine treatment

November 25, 2015
Research and Development Heptares, Teva, collaboration, migraine

Teva Pharmaceuticals and Heptares Therapeutics have signed a licensing and drug-discovery agreement for Teva to gain exclusive global rights to …

News
allergan_pfizer_logos

Pfizer in ‘friendly’ merger talks with Allergan

October 29, 2015
Sales and Marketing Actavis, Allergan, Pfizer, Teva

Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …

News
Teva image

Teva joins Watson Health in R&D link-up

October 14, 2015
Research and Development Big Data, R&D, Teva, Watson Health, ibm

Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …

News
teva

Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015
Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …

News
Teva image

Teva buys majority stake in genomic analysis firm

August 4, 2015
Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis

Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …

News
allergan

Teva to switch generics focus to Allergan

July 27, 2015
Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions

Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …

News
Teva image

Teva ‘to increase Mylan bid to $43bn’

July 7, 2015
Sales and Marketing M&A, MA, Mylan, Teva, generics

Israeli drugmaker Teva is considering whether to up its bid for US rival firm Mylan, with reports that it could …

News
Teva image

FDA accepts Teva asthma drug for review

June 15, 2015
Sales and Marketing AstraZeneca, GlaxoSmithKline’s mepolizumab, Teva, benralizumab, bla, cinquil, reslizumab

Teva’s investigational biologic for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, Cinquil, has been accepted …

News
Perrigo image

Perrigo buys OTC products from GSK

June 3, 2015
Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells

In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …

News
Mylan image

Mylan tells Teva to ‘stop playing games’ and make firm bid

June 2, 2015
Manufacturing and Production, Sales and Marketing M&A, MA, Mylan, Teva, generics

Mylan has written another strongly-worded letter to Teva, this time accusing the Israeli firm of ‘playing games’ and violating US …

News

Teva settles generic ‘pay-to-delay’ case for $1.2 billion

May 29, 2015
Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil

Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …

News
teva_copy

Teva lifted by positive migraine drug results

May 15, 2015
Sales and Marketing TEV-48125, Teva, headaches, migraine

Patients who take either dose of Teva’s investigational treatment for chronic migraine improve more than those taking a placebo according …

News
Teva image

Teva forges ahead with Mylan pursuit

May 6, 2015
Sales and Marketing Mylan, Perrigo, Teva, generics

Teva has reinforced its commitment to buy Mylan despite previous rejection and only days after Mylan upped its own bid …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026